- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Fexofenadine is an allergic symptom in a drug against an antihistamine, such as for the treatment of hay fever and urticaria. Treatment, fexofenadine is a selective peripheral H1 receptor blocker
According to our latest study, the global Fexofenadine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Fexofenadine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Fexofenadine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Fexofenadine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Fexofenadine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Fexofenadine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fexofenadine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fexofenadine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, Titan Pharma and AFCL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Fexofenadine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity:98%
Purity:Above 98%
Market segment by Application
Hay Fever Treatment
Urticaria Treatment
Major players covered
Viruj Pharma
Cemex Pharma
Smaart Pharmaceutticals
Titan Pharma
AFCL
Synkromax
Farmhispania
Gen Pharma
Admiron Life Sciences Private Limited
JRC
Archerchem
Sibram
Sumitomo Chemical
Panchsheel
CAMEO HEALTH CARE
CEPiA-Sanofi
Va Sudha Pharma Chem Limited
VPL Chemicals
Zhejiang Excel Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fexofenadine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fexofenadine, with price, sales, revenue and global market share of Fexofenadine from 2018 to 2023.
Chapter 3, the Fexofenadine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fexofenadine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Fexofenadine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fexofenadine.
Chapter 14 and 15, to describe Fexofenadine sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Fexofenadine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Fexofenadine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity:98%
1.3.3 Purity:Above 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Fexofenadine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hay Fever Treatment
1.4.3 Urticaria Treatment
1.5 Global Fexofenadine Market Size & Forecast
1.5.1 Global Fexofenadine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Fexofenadine Sales Quantity (2018-2029)
1.5.3 Global Fexofenadine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Viruj Pharma
2.1.1 Viruj Pharma Details
2.1.2 Viruj Pharma Major Business
2.1.3 Viruj Pharma Fexofenadine Product and Services
2.1.4 Viruj Pharma Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Viruj Pharma Recent Developments/Updates
2.2 Cemex Pharma
2.2.1 Cemex Pharma Details
2.2.2 Cemex Pharma Major Business
2.2.3 Cemex Pharma Fexofenadine Product and Services
2.2.4 Cemex Pharma Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cemex Pharma Recent Developments/Updates
2.3 Smaart Pharmaceutticals
2.3.1 Smaart Pharmaceutticals Details
2.3.2 Smaart Pharmaceutticals Major Business
2.3.3 Smaart Pharmaceutticals Fexofenadine Product and Services
2.3.4 Smaart Pharmaceutticals Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Smaart Pharmaceutticals Recent Developments/Updates
2.4 Titan Pharma
2.4.1 Titan Pharma Details
2.4.2 Titan Pharma Major Business
2.4.3 Titan Pharma Fexofenadine Product and Services
2.4.4 Titan Pharma Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Titan Pharma Recent Developments/Updates
2.5 AFCL
2.5.1 AFCL Details
2.5.2 AFCL Major Business
2.5.3 AFCL Fexofenadine Product and Services
2.5.4 AFCL Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AFCL Recent Developments/Updates
2.6 Synkromax
2.6.1 Synkromax Details
2.6.2 Synkromax Major Business
2.6.3 Synkromax Fexofenadine Product and Services
2.6.4 Synkromax Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Synkromax Recent Developments/Updates
2.7 Farmhispania
2.7.1 Farmhispania Details
2.7.2 Farmhispania Major Business
2.7.3 Farmhispania Fexofenadine Product and Services
2.7.4 Farmhispania Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Farmhispania Recent Developments/Updates
2.8 Gen Pharma
2.8.1 Gen Pharma Details
2.8.2 Gen Pharma Major Business
2.8.3 Gen Pharma Fexofenadine Product and Services
2.8.4 Gen Pharma Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Gen Pharma Recent Developments/Updates
2.9 Admiron Life Sciences Private Limited
2.9.1 Admiron Life Sciences Private Limited Details
2.9.2 Admiron Life Sciences Private Limited Major Business
2.9.3 Admiron Life Sciences Private Limited Fexofenadine Product and Services
2.9.4 Admiron Life Sciences Private Limited Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Admiron Life Sciences Private Limited Recent Developments/Updates
2.10 JRC
2.10.1 JRC Details
2.10.2 JRC Major Business
2.10.3 JRC Fexofenadine Product and Services
2.10.4 JRC Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 JRC Recent Developments/Updates
2.11 Archerchem
2.11.1 Archerchem Details
2.11.2 Archerchem Major Business
2.11.3 Archerchem Fexofenadine Product and Services
2.11.4 Archerchem Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Archerchem Recent Developments/Updates
2.12 Sibram
2.12.1 Sibram Details
2.12.2 Sibram Major Business
2.12.3 Sibram Fexofenadine Product and Services
2.12.4 Sibram Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sibram Recent Developments/Updates
2.13 Sumitomo Chemical
2.13.1 Sumitomo Chemical Details
2.13.2 Sumitomo Chemical Major Business
2.13.3 Sumitomo Chemical Fexofenadine Product and Services
2.13.4 Sumitomo Chemical Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sumitomo Chemical Recent Developments/Updates
2.14 Panchsheel
2.14.1 Panchsheel Details
2.14.2 Panchsheel Major Business
2.14.3 Panchsheel Fexofenadine Product and Services
2.14.4 Panchsheel Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Panchsheel Recent Developments/Updates
2.15 CAMEO HEALTH CARE
2.15.1 CAMEO HEALTH CARE Details
2.15.2 CAMEO HEALTH CARE Major Business
2.15.3 CAMEO HEALTH CARE Fexofenadine Product and Services
2.15.4 CAMEO HEALTH CARE Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 CAMEO HEALTH CARE Recent Developments/Updates
2.16 CEPiA-Sanofi
2.16.1 CEPiA-Sanofi Details
2.16.2 CEPiA-Sanofi Major Business
2.16.3 CEPiA-Sanofi Fexofenadine Product and Services
2.16.4 CEPiA-Sanofi Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 CEPiA-Sanofi Recent Developments/Updates
2.17 Va Sudha Pharma Chem Limited
2.17.1 Va Sudha Pharma Chem Limited Details
2.17.2 Va Sudha Pharma Chem Limited Major Business
2.17.3 Va Sudha Pharma Chem Limited Fexofenadine Product and Services
2.17.4 Va Sudha Pharma Chem Limited Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Va Sudha Pharma Chem Limited Recent Developments/Updates
2.18 VPL Chemicals
2.18.1 VPL Chemicals Details
2.18.2 VPL Chemicals Major Business
2.18.3 VPL Chemicals Fexofenadine Product and Services
2.18.4 VPL Chemicals Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 VPL Chemicals Recent Developments/Updates
2.19 Zhejiang Excel Pharmaceutical
2.19.1 Zhejiang Excel Pharmaceutical Details
2.19.2 Zhejiang Excel Pharmaceutical Major Business
2.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Product and Services
2.19.4 Zhejiang Excel Pharmaceutical Fexofenadine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Zhejiang Excel Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Fexofenadine by Manufacturer
3.1 Global Fexofenadine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Fexofenadine Revenue by Manufacturer (2018-2023)
3.3 Global Fexofenadine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Fexofenadine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Fexofenadine Manufacturer Market Share in 2022
3.4.2 Top 6 Fexofenadine Manufacturer Market Share in 2022
3.5 Fexofenadine Market: Overall Company Footprint Analysis
3.5.1 Fexofenadine Market: Region Footprint
3.5.2 Fexofenadine Market: Company Product Type Footprint
3.5.3 Fexofenadine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Fexofenadine Market Size by Region
4.1.1 Global Fexofenadine Sales Quantity by Region (2018-2029)
4.1.2 Global Fexofenadine Consumption Value by Region (2018-2029)
4.1.3 Global Fexofenadine Average Price by Region (2018-2029)
4.2 North America Fexofenadine Consumption Value (2018-2029)
4.3 Europe Fexofenadine Consumption Value (2018-2029)
4.4 Asia-Pacific Fexofenadine Consumption Value (2018-2029)
4.5 South America Fexofenadine Consumption Value (2018-2029)
4.6 Middle East and Africa Fexofenadine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Fexofenadine Sales Quantity by Type (2018-2029)
5.2 Global Fexofenadine Consumption Value by Type (2018-2029)
5.3 Global Fexofenadine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Fexofenadine Sales Quantity by Application (2018-2029)
6.2 Global Fexofenadine Consumption Value by Application (2018-2029)
6.3 Global Fexofenadine Average Price by Application (2018-2029)
7 North America
7.1 North America Fexofenadine Sales Quantity by Type (2018-2029)
7.2 North America Fexofenadine Sales Quantity by Application (2018-2029)
7.3 North America Fexofenadine Market Size by Country
7.3.1 North America Fexofenadine Sales Quantity by Country (2018-2029)
7.3.2 North America Fexofenadine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Fexofenadine Sales Quantity by Type (2018-2029)
8.2 Europe Fexofenadine Sales Quantity by Application (2018-2029)
8.3 Europe Fexofenadine Market Size by Country
8.3.1 Europe Fexofenadine Sales Quantity by Country (2018-2029)
8.3.2 Europe Fexofenadine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Fexofenadine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Fexofenadine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Fexofenadine Market Size by Region
9.3.1 Asia-Pacific Fexofenadine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Fexofenadine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Fexofenadine Sales Quantity by Type (2018-2029)
10.2 South America Fexofenadine Sales Quantity by Application (2018-2029)
10.3 South America Fexofenadine Market Size by Country
10.3.1 South America Fexofenadine Sales Quantity by Country (2018-2029)
10.3.2 South America Fexofenadine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Fexofenadine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Fexofenadine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Fexofenadine Market Size by Country
11.3.1 Middle East & Africa Fexofenadine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Fexofenadine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Fexofenadine Market Drivers
12.2 Fexofenadine Market Restraints
12.3 Fexofenadine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Fexofenadine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Fexofenadine
13.3 Fexofenadine Production Process
13.4 Fexofenadine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Fexofenadine Typical Distributors
14.3 Fexofenadine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Fexofenadine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Fexofenadine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Viruj Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Viruj Pharma Major Business
Table 5. Viruj Pharma Fexofenadine Product and Services
Table 6. Viruj Pharma Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Viruj Pharma Recent Developments/Updates
Table 8. Cemex Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Cemex Pharma Major Business
Table 10. Cemex Pharma Fexofenadine Product and Services
Table 11. Cemex Pharma Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Cemex Pharma Recent Developments/Updates
Table 13. Smaart Pharmaceutticals Basic Information, Manufacturing Base and Competitors
Table 14. Smaart Pharmaceutticals Major Business
Table 15. Smaart Pharmaceutticals Fexofenadine Product and Services
Table 16. Smaart Pharmaceutticals Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Smaart Pharmaceutticals Recent Developments/Updates
Table 18. Titan Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Titan Pharma Major Business
Table 20. Titan Pharma Fexofenadine Product and Services
Table 21. Titan Pharma Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Titan Pharma Recent Developments/Updates
Table 23. AFCL Basic Information, Manufacturing Base and Competitors
Table 24. AFCL Major Business
Table 25. AFCL Fexofenadine Product and Services
Table 26. AFCL Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AFCL Recent Developments/Updates
Table 28. Synkromax Basic Information, Manufacturing Base and Competitors
Table 29. Synkromax Major Business
Table 30. Synkromax Fexofenadine Product and Services
Table 31. Synkromax Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Synkromax Recent Developments/Updates
Table 33. Farmhispania Basic Information, Manufacturing Base and Competitors
Table 34. Farmhispania Major Business
Table 35. Farmhispania Fexofenadine Product and Services
Table 36. Farmhispania Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Farmhispania Recent Developments/Updates
Table 38. Gen Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Gen Pharma Major Business
Table 40. Gen Pharma Fexofenadine Product and Services
Table 41. Gen Pharma Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Gen Pharma Recent Developments/Updates
Table 43. Admiron Life Sciences Private Limited Basic Information, Manufacturing Base and Competitors
Table 44. Admiron Life Sciences Private Limited Major Business
Table 45. Admiron Life Sciences Private Limited Fexofenadine Product and Services
Table 46. Admiron Life Sciences Private Limited Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Admiron Life Sciences Private Limited Recent Developments/Updates
Table 48. JRC Basic Information, Manufacturing Base and Competitors
Table 49. JRC Major Business
Table 50. JRC Fexofenadine Product and Services
Table 51. JRC Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. JRC Recent Developments/Updates
Table 53. Archerchem Basic Information, Manufacturing Base and Competitors
Table 54. Archerchem Major Business
Table 55. Archerchem Fexofenadine Product and Services
Table 56. Archerchem Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Archerchem Recent Developments/Updates
Table 58. Sibram Basic Information, Manufacturing Base and Competitors
Table 59. Sibram Major Business
Table 60. Sibram Fexofenadine Product and Services
Table 61. Sibram Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sibram Recent Developments/Updates
Table 63. Sumitomo Chemical Basic Information, Manufacturing Base and Competitors
Table 64. Sumitomo Chemical Major Business
Table 65. Sumitomo Chemical Fexofenadine Product and Services
Table 66. Sumitomo Chemical Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sumitomo Chemical Recent Developments/Updates
Table 68. Panchsheel Basic Information, Manufacturing Base and Competitors
Table 69. Panchsheel Major Business
Table 70. Panchsheel Fexofenadine Product and Services
Table 71. Panchsheel Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Panchsheel Recent Developments/Updates
Table 73. CAMEO HEALTH CARE Basic Information, Manufacturing Base and Competitors
Table 74. CAMEO HEALTH CARE Major Business
Table 75. CAMEO HEALTH CARE Fexofenadine Product and Services
Table 76. CAMEO HEALTH CARE Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CAMEO HEALTH CARE Recent Developments/Updates
Table 78. CEPiA-Sanofi Basic Information, Manufacturing Base and Competitors
Table 79. CEPiA-Sanofi Major Business
Table 80. CEPiA-Sanofi Fexofenadine Product and Services
Table 81. CEPiA-Sanofi Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. CEPiA-Sanofi Recent Developments/Updates
Table 83. Va Sudha Pharma Chem Limited Basic Information, Manufacturing Base and Competitors
Table 84. Va Sudha Pharma Chem Limited Major Business
Table 85. Va Sudha Pharma Chem Limited Fexofenadine Product and Services
Table 86. Va Sudha Pharma Chem Limited Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Va Sudha Pharma Chem Limited Recent Developments/Updates
Table 88. VPL Chemicals Basic Information, Manufacturing Base and Competitors
Table 89. VPL Chemicals Major Business
Table 90. VPL Chemicals Fexofenadine Product and Services
Table 91. VPL Chemicals Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. VPL Chemicals Recent Developments/Updates
Table 93. Zhejiang Excel Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 94. Zhejiang Excel Pharmaceutical Major Business
Table 95. Zhejiang Excel Pharmaceutical Fexofenadine Product and Services
Table 96. Zhejiang Excel Pharmaceutical Fexofenadine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Zhejiang Excel Pharmaceutical Recent Developments/Updates
Table 98. Global Fexofenadine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Fexofenadine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Fexofenadine Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 101. Market Position of Manufacturers in Fexofenadine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Fexofenadine Production Site of Key Manufacturer
Table 103. Fexofenadine Market: Company Product Type Footprint
Table 104. Fexofenadine Market: Company Product Application Footprint
Table 105. Fexofenadine New Market Entrants and Barriers to Market Entry
Table 106. Fexofenadine Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Fexofenadine Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Fexofenadine Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Fexofenadine Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Fexofenadine Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Fexofenadine Average Price by Region (2018-2023) & (USD/Unit)
Table 112. Global Fexofenadine Average Price by Region (2024-2029) & (USD/Unit)
Table 113. Global Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Fexofenadine Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Fexofenadine Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Fexofenadine Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Fexofenadine Average Price by Type (2018-2023) & (USD/Unit)
Table 118. Global Fexofenadine Average Price by Type (2024-2029) & (USD/Unit)
Table 119. Global Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Fexofenadine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Fexofenadine Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Fexofenadine Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Fexofenadine Average Price by Application (2018-2023) & (USD/Unit)
Table 124. Global Fexofenadine Average Price by Application (2024-2029) & (USD/Unit)
Table 125. North America Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Fexofenadine Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Fexofenadine Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Fexofenadine Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Fexofenadine Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Fexofenadine Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Fexofenadine Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Fexofenadine Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Fexofenadine Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Fexofenadine Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Fexofenadine Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Fexofenadine Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Fexofenadine Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Fexofenadine Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Fexofenadine Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Fexofenadine Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Fexofenadine Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Fexofenadine Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Fexofenadine Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Fexofenadine Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Fexofenadine Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Fexofenadine Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Fexofenadine Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Fexofenadine Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Fexofenadine Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Fexofenadine Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Fexofenadine Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Fexofenadine Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Fexofenadine Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Fexofenadine Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Fexofenadine Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Fexofenadine Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Fexofenadine Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Fexofenadine Raw Material
Table 166. Key Manufacturers of Fexofenadine Raw Materials
Table 167. Fexofenadine Typical Distributors
Table 168. Fexofenadine Typical Customers
List of Figures
Figure 1. Fexofenadine Picture
Figure 2. Global Fexofenadine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Fexofenadine Consumption Value Market Share by Type in 2022
Figure 4. Purity:98% Examples
Figure 5. Purity:Above 98% Examples
Figure 6. Global Fexofenadine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Fexofenadine Consumption Value Market Share by Application in 2022
Figure 8. Hay Fever Treatment Examples
Figure 9. Urticaria Treatment Examples
Figure 10. Global Fexofenadine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Fexofenadine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Fexofenadine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Fexofenadine Average Price (2018-2029) & (USD/Unit)
Figure 14. Global Fexofenadine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Fexofenadine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Fexofenadine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Fexofenadine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Fexofenadine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Fexofenadine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Fexofenadine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Fexofenadine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Fexofenadine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Fexofenadine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Fexofenadine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Fexofenadine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Fexofenadine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Fexofenadine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Fexofenadine Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global Fexofenadine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Fexofenadine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Fexofenadine Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America Fexofenadine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Fexofenadine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Fexofenadine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Fexofenadine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Fexofenadine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Fexofenadine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Fexofenadine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Fexofenadine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Fexofenadine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Fexofenadine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Fexofenadine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Fexofenadine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Fexofenadine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Fexofenadine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Fexofenadine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Fexofenadine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Fexofenadine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Fexofenadine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Fexofenadine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Fexofenadine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Fexofenadine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Fexofenadine Market Drivers
Figure 73. Fexofenadine Market Restraints
Figure 74. Fexofenadine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Fexofenadine in 2022
Figure 77. Manufacturing Process Analysis of Fexofenadine
Figure 78. Fexofenadine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
